Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Katsunori Miyake has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • C-20 oxidized furylethyl clerodane diterpenes isolated from Croton argyratus and their antifungal activity

    by Kanami Watanabe, Rintaro Muroda, Daisuke Yamanaka, Yohei Saito, Shuichi Fukuyoshi, Katsunori Miyake, David J. Newman, Barry R. O'KEefe, Kuo-Hsiung Lee, Kyoko Nakagawa-Goto

  • Supporting exploration and sustainable utilization of the medicinal plant Uncaria rhynchophylla in Kyushu, Japan through potential distribution modeling using MaxEnt and GIS

    by Toshiyuki Atsumi, Suzuka Hokazono, Kaito Kikuchi, Taichi Fujii, Kiyoshi Takejima, Mikiyo Wada, Katsunori Miyake, Tadahiro Yahagi, Kenichi Nakamura, Akihito Takano, et al.

    Sustainable utilization of wild medicinal plant resources requires reproducible approaches for locating and managing natural populations. In Japan, exploration and resource planning for wild medicinal plants rely heavily on expert knowledge, and reproducible approaches remain scarce. We developed a species distribution model (SDM) for Uncaria rhynchophylla (Rubiaceae), a botanical source of the crude drug Uncaria Hook used in Kampo medicine, to estimate its potential distribution and identify major environmental correlates in the Kyushu region, southern Japan. Using 122 occurrence records collected from 2021 to 2023 and nine environmental predictors, MaxEnt models were trained with background points and bootstrap replicates. Because mean minimum winter temperature in January and mean maximum summer temperature in August were highly correlated, three candidate models were compared using the small-sample corrected Akaike information criterion (AICc), test omission rates, and test area under the receiver operating characteristic curve (AUC). The model including winter minimum temperature was best supported (test AUC = 0.82; test omission rate = 24%), whereas adding summer maximum temperature provided limited improvement (ΔAICc = + 75.75). Variable importance and jackknife tests ranked winter minimum temperature as the most influential predictor, followed by slope angle and distance to the nearest rivers. The suitable area, defined using the maximum training sensitivity plus specificity (MTSS) threshold, covered 10,595 km² (25.9% of the terrestrial area) and formed continuous zones across hilly and low-montane regions. Targeted surveys in high-suitability areas confirmed three additional sites in the Kirishima Mountains. Overall, integrating SDM and geographic information systems provides a reproducible, data-driven, decision-support framework for the exploration, planning of sustainable harvesting, and resource management of wild medicinal plants.

  • Effects of nutrient conditions to stem photosynthesis and growth in Ephedra intermedia (Ephedraceae)

    by Haruka Tokuda, Mahiro Sekiguchi, Hinata Kaneda, Kanami Toyoizumi, Yusuke Mizokami, Masayuki Mikage, Katsunori Miyake, Ko Noguchi


  • Open Access

    Unusual Vilasinin-Class Limonoids from Trichilia rubescens

    by Saidanxia Amuti, Yohei Saito, Shuichi Fukuyoshi, Katsunori Miyake, David J. Newman, Barry R. O’keefe, Kuo-Hsiung Lee, Kyoko Nakagawa-Goto

    Eight vilasinin-class limonoids, including the unusually chlorinated rubescins K–M (1–3), the 2,3-epoxylated rubescin N (4), and rubescins O–R (5–8), were newly isolated from Trichilia rubescens. The structures of the isolated compounds were determined through spectroscopic and spectrometric analyses, as well as ECD calculations. The natural occurrence of chlorinated limonoids 1–3 was confirmed by chemical methods and HPLC analysis of a roughly fractionated portion of the plant extract. Eight selected limonoids, including previously known and new compounds, were evaluated for antiproliferative activity against five human tumor cell lines. All tested limonoids, except 8, exhibited significant potency, with IC50 values of 50 values of 0.54–2.06 μM against all tumor cell lines, including multi-drug-resistant cells.


  • Methoxyflavones isolated from the whole plant of Scutellaria rubropunctata Hayata var. rubropunctata promote osteoblast differentiation in MC3T3-E1 cells

    by Misaki Watanabe, Tadahiro Yahagi, Rina Kamikura, Hitoshi Kotani, Katsunori Miyake, Keiichi Matsuzaki

    In this study, we isolated two new methoxyflavones (1 and 2) and eight known methoxyflavones (3–10) from the whole plant of Scutellaria rubropunctata Hayata var. rubropunctata (SR). Based on spectroscopic analyses, the methoxyflavones were identified as 5,8,2′,6′-tetramethoxy-6,7-methylenedioxyflavone (1) and 5,2′,6′-trimethoxy-6,7-methylenedioxyflavone (2). We reported SR might have effects on promoting osteoblast differentiation and stimulating estrogen receptor (ER) in the previous study. Then, the effects of 1–10 on pre-osteoblast MC3T3-E1 cells were investigated, and 1, 2, and 9 were observed to promote alkaline phosphatase activity. To evaluate their effect on osteogenesis-related genes, we performed gene expression analysis using quantitative real-time PCR after treatment of MC3T3-E1 cells with these compounds. Although 2 was only effective at lower concentrations, 1 and 9 upregulated the mRNA levels of Runx2, Osterix, Osteopontin, Osteocalcin, Smad1, and Smad4. These results indicate that 1 and 9 may induce osteoblast differentiation by activating Runx2 via the BMP/Smad pathway and may play a central role in the promotion of osteoblast differentiation by SR. The ER agonist activity of 1–10 were tested using a luciferase reporter assay in HEK293 cells. However, none of the compounds exhibited remarkable activity. Thus, SR may contain other compounds that contribute to its ER agonist activity. Graphical abstract


  • Open Access

    Effects of a Whole Plant Extract of Scutellaria rubropunctata var. rubropunctata on Bone Metabolism with Estrogen Receptor Activation

    by Misaki Watanabe, Tadahiro Yahagi, Takahiro Shirayama, Katsunori Miyake, Hitoshi Kotani, Takuya Ogawa, Keiichi Matsuzaki

    We screened natural resources for estrogen receptor (ER)-activating and bone metabolism-promoting activities with the aim of finding potential treatments for osteoporosis. A screen of 1531 extracts from Ryukyu Arc plants using a luciferase reporter assay identified an 80% MeOH extract of Scutellaria rubropunctata var. rubropunctata (SRE) with dose-dependent ER transcription-promoting activity. Importantly, SRE had no proliferative effect on human breast cancer cells. SRE enhanced the ALP activity of pre-osteoblast MC3T3-E1 cells after 72 h in culture and slightly enhanced mineralization at 14 and 21 d. SRE did not significantly affect the TRAP activity of RAW264.7 cells. Gene expression analysis in MC3T3-E1 cells by quantitative real-time PCR revealed that SRE upregulated the mRNA levels of Runx2, Osterix (Osx), Osteopontin (Opn), Osteocalcin (Ocn), Smad1, Smad4, and Smad5 at 72 h, and those of Runx2, Osx, Smad1, Smad4, and Smad5 at 21 d of osteogenic induction. Analysis of the expression levels of osteogenic markers suggested that SRE may promote osteogenic differentiation by acting at the early stage of differentiation rather than at the late stage of differentiation. These results indicate that SRE activates ER and induces osteoblast differentiation by activating Runx2 and Osx through the BMP/Smad pathway, suggesting that SRE may be useful for the prevention and treatment of postmenopausal osteoporosis.


  • Open Access

    Retusone A, a Guaiane-Type Sesquiterpene Dimer from Wikstroemia retusa and Its Inhibitory Effects on Histone Acetyltransferase HBO1 Expression

    by Young Sook Yun, Tomomi Nakano, Haruhiko Fukaya, Yukio Hitotsuyanagi, Miho Nakamura, Megumi Umetsu, Nobuko Matsushita, Katsunori Miyake, Hiroyuki Fuchino, Nobuo Kawahara, et al.

    Retusone A (1), a new sesquiterpene dimer consisting of two guaiane-type sesquiterpenoids, and oleodaphnal (2) were isolated from heartwood of Wikstroemia retusa (Thymelaeaceae). The planar structure of 1 was elucidated on the basis of HRESIMS and NMR spectroscopic data, and the relative stereochemistry was established by X-ray diffraction analysis. The absolute configuration of 1 was determined by electronic circular dichroism. Compound 1 suppressed luciferase reporter gene expression driven by the HBO1 (histone acetyltransferase binding to ORC1) gene promoter in human breast cancer MCF7 cells. Compound 1 also decreased the expression of endogenous HBO1 mRNA and protein, and inhibited proliferation of the cells. These results suggest that retusone A (1), which has a unique dimeric sesquiterpenoid structure with inhibitory activity against HBO1 expression, may contribute to the development of a novel therapeutic candidate for the treatment of breast cancer.


  • Open Access

    Isolation, Structure Elucidation, and Antiproliferative Activity of Butanolides and Lignan Glycosides from the Fruit of Hernandia nymphaeifolia

    by Simayijiang Aimaiti, Yohei Saito, Shuichi Fukuyoshi, Masuo Goto, Katsunori Miyake, David J. Newman, Barry R. O’keefe, Kuo-Hsiung Lee, Kyoko Nakagawa-Goto

    Seven new butanolides, peltanolides A–G (1–7), and two lignan glucosides, peltasides A (8) and B (9), along with eleven known compounds, 10–20, were isolated from a crude CH3OH/CH2Cl2 (1:1) extract of the fruit of Hernandia nymphaeifolia (Hernandiaceae). The structures of 1–9 were characterized by extensive 1D and 2D NMR spectroscopic and HRMS analysis. The absolute configurations of newly isolated compounds 1–9 were determined from data obtained by optical rotation and electronic circular dichroism (ECD) exciton chirality methods. Butanolides and lignan glucosides have not been isolated previously from this genus. Several isolated compounds were evaluated for antiproliferative activity against human tumor cell lines. Lignans 15 and 16 were slightly active against chemosensitive tumor cell lines A549 and MCF-7, respectively. Furthermore, both compounds displayed significant activity (IC50 = 5 µM) against a P-glycoprotein overexpressing multidrug-resistant tumor cell line (KB-VIN) but were less active against its parent chemosensitive cell line (KB).


  • Spiro[3.5]nonenyl Meroterpenoid Lactones, Cryptolaevilactones G–L, an Ionone Derivative, and Total Synthesis of Cryptolaevilactone M from Cryptocarya laevigata

    by Fumika Tsurumi, Yuta Miura, Misaki Nakano, Yohei Saito, Shuichi Fukuyoshi, Katsunori Miyake, David J. Newman, Barry R. O’kEefe, Kuo-Hsiung Lee, Kyoko Nakagawa-Goto

    A CH3OH–CH2Cl2 (1:1) extract (N025439) of the leaves and twigs of Cryptocarya laevigata furnished eight new compounds, 1–8. Based on extensive 1D and 2D NMR spectroscopic data examination, the new δ-lactone derivatives 1–6 are monoterpene–polyketide hybrids containing a unique spiro[3.5]nonenyl moiety. Their trivial names, cryptolaevilactones G–L, follow those of the related known meroterpenoids cryptolaevilactones A–F. Cryptolaevilactone L (6) contains 11,12-cis-oriented substituents, while the other cryptolaevilactones contain trans-oriented groups. The structure of the linear δ-lactone 7, cryptolaevilactone M, was characterized from various spectroscopic data analysis, and the absolute configuration was determined by total synthesis through stereoselective allylation and Grubbs olefin metathesis. Compound 8 was elucidated to be an ionone derivative with a 3,4-syn-diol functionality.


  • Antiproliferative Alkaloids from Alangium longiflorum, an Endangered Tropical Plant Species

    by Misa Takeuchi, Yohei Saito, Masuo Goto, Katsunori Miyake, David J. Newman, Barry R. O’keefe, Kuo-Hsiung Lee, Kyoko Nakagawa-Goto

    Alangium longiflorum is currently in extinction crisis, which will likely severely hamper further phytochemical investigation of this plant species from new collections. A crude extract of leaves of A. longiflorum (N33539), collected for the U.S. National Cancer Institute in 1989, showed potent cancer cell line antiproliferative activity. A phytochemical study resulted in the isolation of 17 secondary metabolites, including two new tetrahydroisoquinoline alkaloids, 8-hydroxytubulosine (1) and 2′-O-trans-sinapoylisoalangiside (2), as well as a new sinapolyloxylupene derivative (3). Using in-house assays and NCI-60 panel screening, compound 1 displayed broad-spectrum inhibitory activity at submicromolar levels against most tested tumor cell lines, except for drug-transporter-overexpressing cells. Compound 1 caused accumulation of sub-G1 cells with no effect on cell cycle progression, suggesting that this substance is an apoptosis inducer.